The U.S. Food and Drug Administration (FDA) has provided an update on its partnership with Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) and the Mexican Federal Commission for Protection against Sanitary Risk (COFEPRIS).
The U.S. Department of Agriculture’s Food Safety and Inspection Service’s (USDA’s FSIS) has announced that is granting a pilot project to Pilgrim’s Pride in Mount Pleasant, Texas to examine the merits and logistics of excluding Salmonella poultry vaccine strains from the FSIS Salmonella performance categorization calculation.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s FSIS) has published two reports on its foodborne illness outbreak investigations and sampling activities for fiscal year 2022.
Approximately 46 percent of honey imported to the EU is adulterated, according to the European Food Safety Authority (EFSA). These findings are the result of an EU-coordinated action, titled, “From the Hives.”
The UK Food Standards Agency (FSA) recently conducted an analysis of hazards associated with cultured meat products (also known as “cell-based” or “cultivated” meat) and identified several risk areas while acknowledging that there are still existing knowledge and data gaps.
The University of Vermont Extension’s Northeast Center to Advance food Safety (UVM’s NECAFS) has released a series of factsheets on produce safety in hydroponic and aquaponic operations for educators, regulators, and producers. The new factsheets guide readers through produce safety considerations specific to hydroponic and aquaponic operations.
The level of consumer exposure to genotoxic and carcinogenic nitrosamines in foods raise a public health concern, according to the European Food Safety Authority (EFSA).
In a letter distributed by the U.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition (FDA’s CFSAN) to FDA staff, CFSAN Director Susan T. Mayne, Ph.D. announced that she will be stepping down from her position on May 31, 2023.
On March 8, 2023, the U.S. Food and Drug Administration (FDA) released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. On the same day, the agency’s response to the recent infant formula safety and supply crisis was called into question during a hearing with the U.S. House of Representatives Subcommittee on Health Care and Financial Services Hearing.